Published

Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 2026-07-20
Source: Europe PMC
DOI: 10.1002/bcp.70690
PubMed: 42482371

Authors

Cervera-Sanchez MB San-Juan D Díaz-Peregrino R Camacho-Castillo EZ Bringas-Ortiz SA Padilla-Cabezutd C.

Watch author

Derived topics and classifications

psilocybin Receptor Pharmacology Clinical Trial Review Article Animal Study Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-16 Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challengesJournal of Psychiatric Research · 2026-06-22 Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for CliniciansDrugs · 2026-06-03 Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-15 Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open MIND · 2026-07-08 Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.International Journal of Eating Disorders · 2026-07-01 Sex-dependent effects of psychedelics: review of evidence from rodent modelsFrontiers in Psychiatry · 2026-07-14 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-02